BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 17327378)

  • 1. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
    Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
    J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue.
    Mai K; Andres J; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):419-25. PubMed ID: 17555498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT).
    Woods CP; Corrigan M; Gathercole L; Taylor A; Hughes B; Gaoatswe G; Manolopoulos K; Hogan AE; O'Connell J; Stewart PM; Tomlinson JW; O'Shea D; Sherlock M
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1434-44. PubMed ID: 25603461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific dysregulation of cortisol metabolism in human obesity.
    Rask E; Olsson T; Söderberg S; Andrew R; Livingstone DE; Johnson O; Walker BR
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1418-21. PubMed ID: 11238541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary macronutrient content alters cortisol metabolism independently of body weight changes in obese men.
    Stimson RH; Johnstone AM; Homer NZ; Wake DJ; Morton NM; Andrew R; Lobley GE; Walker BR
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4480-4. PubMed ID: 17785367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children.
    Wang J; Sun B; Hou M; Pan X; Li X
    Int J Obes (Lond); 2013 Jul; 37(7):999-1005. PubMed ID: 23090578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans.
    Stimson RH; Andersson J; Andrew R; Redhead DN; Karpe F; Hayes PC; Olsson T; Walker BR
    Diabetes; 2009 Jan; 58(1):46-53. PubMed ID: 18852329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of regulation of 11beta-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism.
    Sigurjonsdottir HA; Andrew R; Stimson RH; Johannsson G; Walker BR
    Eur J Endocrinol; 2009 Sep; 161(3):375-80. PubMed ID: 19549748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
    Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
    Paulsen SK; Pedersen SB; Fisker S; Richelsen B
    Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11β-hydroxysteroid dehydrogenase types 1 and 2 activity in subcutaneous adipose tissue in humans: implications in obesity and diabetes.
    Dube S; Norby BJ; Pattan V; Carter RE; Basu A; Basu R
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E70-6. PubMed ID: 25303491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone stimulates adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in a depot-specific manner in children.
    Zhu L; Hou M; Sun B; Burén J; Zhang L; Yi J; Hernell O; Li X
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3300-8. PubMed ID: 20410225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute in vivo regulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans.
    Wake DJ; Homer NZ; Andrew R; Walker BR
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4682-8. PubMed ID: 16954164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
    Tomlinson JW; Sinha B; Bujalska I; Hewison M; Stewart PM
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5630-5. PubMed ID: 12466364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11beta-hydroxysteroid dehydrogenase type 1 of the subcutaneous adipose tissue is dysregulated but not associated with metabolic disorders in adults born small for gestational age.
    Meas T; Carreira E; Wang Y; Rauh M; Poitou C; Clément K; Dötsch J; Lévy-Marchal C
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3949-54. PubMed ID: 20519348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition.
    Stimson RH; Andrew R; McAvoy NC; Tripathi D; Hayes PC; Walker BR
    Diabetes; 2011 Mar; 60(3):720-5. PubMed ID: 21266326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.
    Westerbacka J; Yki-Järvinen H; Vehkavaara S; Häkkinen AM; Andrew R; Wake DJ; Seckl JR; Walker BR
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4924-31. PubMed ID: 14557475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
    Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.